Sangam Health Care Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve 1. Unaudited financial ....
Awaiting price reaction for this filing.
Sangam Health Care Products Ltd has informed BSE that its Board of Directors will meet on 14 August 2025 at the registered office. The agenda includes consideration and approval of the unaudited financial results for the quarter ended 30 June 2025 (Q1 FY26) along with the Limited Review Report. Any other business may also be taken up with the Chair's permission. No financial figures have been disclosed in this filing — results will be announced after the board meeting. The intimation is signed by Managing Director D. Bhagat Reddy.
This is a routine regulatory intimation with no direct impact on the stock. Investors should track the actual Q1 results announcement on or after 14 August 2025 to gauge quarterly performance.